Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
The client has been ordered allopurinol (Zyloprim) and is preparing for discharge. What should the nurse include in the discharge instructions?
A. This medication will target the inflammation and pain during an acute attack
Allopurinol does not directly target inflammation or pain in acute gout attacks; it lowers uric acid levels to prevent future attacks. Anti-inflammatories like NSAIDs or colchicine manage acute symptoms. This statement is inaccurate, as allopurinol’s role is preventive, not for acute symptom relief.
B. This medication decreases the production of uric acid
Allopurinol inhibits xanthine oxidase, reducing uric acid production, which prevents urate crystal formation and gout attacks. It is used for long-term management of hyperuricemia. This statement is accurate, as decreased uric acid production is the primary mechanism, critical for patient education on its purpose.
C. Kidney function tests are not necessary when using this medication
Kidney function tests are necessary with allopurinol, as it is renally excreted, and impaired renal function can increase toxicity risk (e.g., rash, interstitial nephritis). Monitoring ensures safe use, especially in gout patients with potential renal issues, making this statement inaccurate for discharge instructions.
D. Limit fluid intake to 1000cc per day to prevent urinary incontinence
Limiting fluid intake to 1000cc daily is inappropriate; high fluid intake (2-3L/day) is recommended with allopurinol to prevent urate kidney stones by diluting urine. This statement is inaccurate, as it contradicts the need for hydration to support uric acid excretion and prevent complications.
This question is an excerpt from Nurse Dive's nursing test bank - Pathophamacology Proctored Exam (Examplify). Take the full exam now
Full Explanation
Choice A reason: Allopurinol does not directly target inflammation or pain in acute gout attacks; it lowers uric acid levels to prevent future attacks. Anti-inflammatories like NSAIDs or colchicine manage acute symptoms. This statement is inaccurate, as allopurinol’s role is preventive, not for acute symptom relief.
Choice B reason: Allopurinol inhibits xanthine oxidase, reducing uric acid production, which prevents urate crystal formation and gout attacks. It is used for long-term management of hyperuricemia. This statement is accurate, as decreased uric acid production is the primary mechanism, critical for patient education on its purpose.
Choice C reason: Kidney function tests are necessary with allopurinol, as it is renally excreted, and impaired renal function can increase toxicity risk (e.g., rash, interstitial nephritis). Monitoring ensures safe use, especially in gout patients with potential renal issues, making this statement inaccurate for discharge instructions.
Choice D reason: Limiting fluid intake to 1000cc daily is inappropriate; high fluid intake (2-3L/day) is recommended with allopurinol to prevent urate kidney stones by diluting urine. This statement is inaccurate, as it contradicts the need for hydration to support uric acid excretion and prevent complications.
Similar Questions
The nurse is caring for a client who reports periods of exacerbations and remissions of bloody diarrhea and abdominal pain. A recent X-ray indicated a continuous pattern of lesions in the large bowel. What underlying condition does the nurse suspect?
A. Colorectal cancer
Colorectal cancer may cause bleeding or pain but typically presents with mass lesions or obstruction, not a continuous pattern of mucosal lesions on X-ray. Its symptoms are less likely to remit and exacerbate cyclically, unlike inflammatory bowel diseases, making it less likely than ulcerative colitis.
B. Crohn’s disease
Crohn’s disease causes patchy, transmural bowel lesions, not continuous large bowel involvement. Its skip lesions and potential for small bowel involvement distinguish it from the continuous mucosal inflammation seen in ulcerative colitis, making this an inaccurate diagnosis for the described X-ray findings.
C. Diverticulitis
Diverticulitis involves inflamed diverticula, typically causing localized pain and fever, not continuous large bowel lesions or bloody diarrhea with remissions. X-ray may show diverticula, but not diffuse mucosal involvement. This condition is less likely than ulcerative colitis given the described symptom pattern.
D. Ulcerative colitis
Ulcerative colitis causes continuous mucosal inflammation in the large bowel, leading to bloody diarrhea, abdominal pain, and periods of exacerbation and remission. X-ray showing continuous lesions aligns with its diffuse colitis pattern, making this the most accurate diagnosis for the client’s symptoms and findings.
Full Explanation
Choice A reason: Colorectal cancer may cause bleeding or pain but typically presents with mass lesions or obstruction, not a continuous pattern of mucosal lesions on X-ray. Its symptoms are less likely to remit and exacerbate cyclically, unlike inflammatory bowel diseases, making it less likely than ulcerative colitis.
Choice B reason: Crohn’s disease causes patchy, transmural bowel lesions, not continuous large bowel involvement. Its skip lesions and potential for small bowel involvement distinguish it from the continuous mucosal inflammation seen in ulcerative colitis, making this an inaccurate diagnosis for the described X-ray findings.
Choice C reason: Diverticulitis involves inflamed diverticula, typically causing localized pain and fever, not continuous large bowel lesions or bloody diarrhea with remissions. X-ray may show diverticula, but not diffuse mucosal involvement. This condition is less likely than ulcerative colitis given the described symptom pattern.
Choice D reason: Ulcerative colitis causes continuous mucosal inflammation in the large bowel, leading to bloody diarrhea, abdominal pain, and periods of exacerbation and remission. X-ray showing continuous lesions aligns with its diffuse colitis pattern, making this the most accurate diagnosis for the client’s symptoms and findings.
The client states they are experiencing constipation. What tool would not be included in the assessment of this condition?
A. Presence of kidney disease
Kidney disease does not directly cause constipation. While it may cause fluid imbalances or medication side effects, it is not a primary factor in assessing constipation. Bowel function is more influenced by diet, activity, and medications, making kidney disease irrelevant as a routine assessment tool for this condition.
B. Description of dietary intake
Dietary intake, particularly low fiber or inadequate hydration, is a primary cause of constipation. Assessing fiber, fluid, and food types helps identify contributing factors, as low-fiber diets slow intestinal transit. This tool is essential in evaluating constipation, as diet directly impacts stool consistency and frequency.
C. Description of activities routinely performed
Routine physical activity affects bowel motility, as sedentary lifestyles slow peristalsis, contributing to constipation. Assessing activity levels identifies whether lack of movement is a factor. This tool is critical, as exercise promotes intestinal transit, making it a key component in constipation assessment.
D. Medication history
Medication history is vital, as drugs like opioids, anticholinergics, or calcium supplements can cause constipation by slowing gut motility or altering fluid balance. Assessing medications identifies potential causes, making this tool essential for a comprehensive constipation evaluation to guide appropriate interventions.
Full Explanation
Choice A reason: Kidney disease does not directly cause constipation. While it may cause fluid imbalances or medication side effects, it is not a primary factor in assessing constipation. Bowel function is more influenced by diet, activity, and medications, making kidney disease irrelevant as a routine assessment tool for this condition.
Choice B reason: Dietary intake, particularly low fiber or inadequate hydration, is a primary cause of constipation. Assessing fiber, fluid, and food types helps identify contributing factors, as low-fiber diets slow intestinal transit. This tool is essential in evaluating constipation, as diet directly impacts stool consistency and frequency.
Choice C reason: Routine physical activity affects bowel motility, as sedentary lifestyles slow peristalsis, contributing to constipation. Assessing activity levels identifies whether lack of movement is a factor. This tool is critical, as exercise promotes intestinal transit, making it a key component in constipation assessment.
Choice D reason: Medication history is vital, as drugs like opioids, anticholinergics, or calcium supplements can cause constipation by slowing gut motility or altering fluid balance. Assessing medications identifies potential causes, making this tool essential for a comprehensive constipation evaluation to guide appropriate interventions.
Which lab result would be consistent with a diagnosis of rheumatoid arthritis?
A. Elevated rheumatoid factor
Elevated rheumatoid factor (RF), an autoantibody, is present in 70-80% of rheumatoid arthritis (RA) patients. It contributes to immune complex formation, driving synovial inflammation and joint damage. This lab result is a key diagnostic marker, making it consistent with RA and critical for confirming the diagnosis.
B. Decreased C-reactive protein
Decreased C-reactive protein (CRP) is inconsistent with RA, which typically shows elevated CRP due to systemic inflammation. CRP reflects acute-phase response in active RA, and low levels suggest inactive disease or another condition, making this result inaccurate for supporting an RA diagnosis.
C. Normal erythrocyte sedimentation rate
Normal erythrocyte sedimentation rate (ESR) is not typical in active RA, where ESR is elevated due to inflammation-driven increases in plasma proteins. Normal ESR may occur in remission but does not support an active RA diagnosis, making this result inconsistent with the condition.
D. Low antinuclear antibody levels
Low antinuclear antibody (ANA) levels are not specific to RA and are more associated with systemic lupus erythematosus. While some RA patients may have low ANA, it is not a diagnostic marker for RA, making this result irrelevant and inconsistent with confirming rheumatoid arthritis.
Full Explanation
Choice A reason: Elevated rheumatoid factor (RF), an autoantibody, is present in 70-80% of rheumatoid arthritis (RA) patients. It contributes to immune complex formation, driving synovial inflammation and joint damage. This lab result is a key diagnostic marker, making it consistent with RA and critical for confirming the diagnosis.
Choice B reason: Decreased C-reactive protein (CRP) is inconsistent with RA, which typically shows elevated CRP due to systemic inflammation. CRP reflects acute-phase response in active RA, and low levels suggest inactive disease or another condition, making this result inaccurate for supporting an RA diagnosis.
Choice C reason: Normal erythrocyte sedimentation rate (ESR) is not typical in active RA, where ESR is elevated due to inflammation-driven increases in plasma proteins. Normal ESR may occur in remission but does not support an active RA diagnosis, making this result inconsistent with the condition.
Choice D reason: Low antinuclear antibody (ANA) levels are not specific to RA and are more associated with systemic lupus erythematosus. While some RA patients may have low ANA, it is not a diagnostic marker for RA, making this result irrelevant and inconsistent with confirming rheumatoid arthritis.